Pharmos Corporation
Patent Applications and Registrations
Patent applications and USPTO patent grants for Pharmos Corporation.The latest application filed is for "method of lowering serum uric acid levels with (s)-tofisopam".
- Pharmos Corporation - Iselin NJ
- PHARMOS CORPORATION - West Palm Beach FL
- Pharmos Corporation -
- Pharmos Corporation - New York NY
- Pharmos Corp. - New York NY
- Pharmos Corporation - Alachua FL
Trademarks
| Patent | Date |
|---|---|
| Sulfonamide derivatives with therapeutic indications Grant 9,422,235 - Yacovan , et al. August 23, 2 | 2016-08-23 |
| Method of lowering serum uric acid levels with (S)-tofisopam Grant 9,408,852 - Gidner , et al. August 9, 2 | 2016-08-09 |
| Method of Lowering Serum Uric Acid Levels With (S)-Tofisopam App 20130045966 - Gidner; Judi ; et al. | 2013-02-21 |
| Orally Effective Cannabinoid Analogs App 20090068143 - Yacovan; Avihai ; et al. | 2009-03-12 |
| Benzofuran Derivatives With Therapeutic Activities App 20090054376 - Yacovan; Avihai ; et al. | 2009-02-26 |
| Novel Non-psychotropic Cannabinoids App 20070213369 - Garzon; Aaron ; et al. | 2007-09-13 |
| Non-psychotropic cannabinoids Grant 7,235,584 - Garzon , et al. June 26, 2 | 2007-06-26 |
| Non-psychotropic cannabinoids Grant 6,610,737 - Garzon , et al. August 26, 2 | 2003-08-26 |
| Enhanced anti-angiogenic activity of permanently charged derivatives of steroid hormones Grant 6,083,990 - Biegon , et al. July 4, 2 | 2000-07-04 |
| Topical and transdermal delivery system utilizing submicron oil spheres Grant 6,004,566 - Friedman , et al. December 21, 1 | 1999-12-21 |
| Bioadhesive emulsion preparations for enhanced drug delivery Grant 5,993,846 - Friedman , et al. November 30, 1 | 1999-11-30 |
| Submicron emulsions as vaccine adjuvants Grant 5,961,970 - Lowell , et al. October 5, 1 | 1999-10-05 |
| Solid Coprecipitates for enhanced bioavailability of lipophilic substances Grant 5,891,469 - Amselem April 6, 1 | 1999-04-06 |
| Dry compositions for preparing submicron emulsions Grant 5,750,142 - Friedman , et al. May 12, 1 | 1998-05-12 |
| Suspension of loteprednol etabonate for ear, eye, or nose treatment Grant 5,747,061 - Amselem , et al. May 5, 1 | 1998-05-05 |
| Solid fat nanoemulsions as vaccine delivery vehicles Grant 5,716,637 - Anselem , et al. February 10, 1 | 1998-02-10 |
| Solid fat nanoemulsions Grant 5,662,932 - Amselem , et al. September 2, 1 | 1997-09-02 |
| Permanently ionic derivatives of steroid hormones and their antagonists Grant 5,650,425 - Biegnon , et al. July 22, 1 | 1997-07-22 |
| Solid fat nanoemulsions as drug delivery vehicles Grant 5,576,016 - Amselem , et al. November 19, 1 | 1996-11-19 |
| Cyclodextrins as suspending agents for pharmaceutical suspensions Grant 5,576,311 - Guy November 19, 1 | 1996-11-19 |
| Suspension of loteprednol etabonate for ear, eye, or nose treatment Grant 5,540,930 - Guy , et al. July 30, 1 | 1996-07-30 |
| NMDA-blocking pharmaceuticals Grant 5,521,215 - Mechoulam , et al. | 1996-05-28 |
| Submicron emulsions for delivery of peptides Grant 5,514,670 - Friedman , et al. May 7, 1 | 1996-05-07 |
| Submicron emulsions as ocular drug delivery vehicles Grant 5,496,811 - Aviv , et al. March 5, 1 | 1996-03-05 |
| Neuroprotective pharmaceutical compositions of 4-phenylpinene derivatives and certain novel 4-phenylpinene compounds Grant 5,434,295 - Mechoulam , et al. | 1995-07-18 |
| NCAGE Code | 60WD9 | PHARMOS CORPORATION |
| CAGE Code | 60WD9 | PHARMOS CORPORATION |
| SEC | 0000713275 | PHARMOS CORP of NEVADA |
| SEC | 0000880042 | PHARMOS CORPORATION |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 